Overview

AlloMap: The Standard of Care for Managing Heart Transplant Recipients

Whether you are getting your first AlloMap® test or AlloMap is already part of your post-transplant care, this site provides general information about AlloMap and how it benefits your post-transplant care.

AlloMap is widely used and accepted

Since 2005, CareDx has made a number of achievements with AlloMap. In the last ten years there are over:

In addition, AlloMap has been included in the International Society of Heart and Lung Transplantation (ISHLT) guidelines since 2008.1

The International Society for Heart and Lung Transplantation (ISHLT) is a not-for-profit, multidisciplinary, professional organization dedicated to improving the care of patients with advanced heart or lung disease through transplantation, mechanical support and innovative therapies via research, education and advocacy.2

References:

  1. Costanzo MR, Dipchand A, Starling RC, et al. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2010;29(8):914-956.
  2. http://www.ishlt.org/guidelines/